0001209191-13-022799.txt : 20130426 0001209191-13-022799.hdr.sgml : 20130426 20130426171507 ACCESSION NUMBER: 0001209191-13-022799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130424 FILED AS OF DATE: 20130426 DATE AS OF CHANGE: 20130426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGER ROBERT CENTRAL INDEX KEY: 0001239757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52089 FILM NUMBER: 13788341 MAIL ADDRESS: STREET 1: 98 MONTVALE RD CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 4 1 c527377_4x0.xml MAIN DOCUMENT DESCRIPTION X0306 4 2013-04-24 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. NVIV 0001239757 LANGER ROBERT 98 MONTVALE ROAD NEWTON MA 02459 0 0 1 0 COMMON STOCK 2013-04-24 4 S 0 2500 2.962 D 7503878 D COMMON STOCK 2013-04-25 4 S 0 2500 2.944 D 7501378 D COMMON STOCK 2013-04-26 4 S 0 2500 2.8508 D 7498878 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $2.98, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.94 to $2.95, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.88, inclusive. /S/ ELIZABETH FRASER, ATTORNEY-IN-FACT 2013-04-26